Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1571679

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571679

Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Ultrafiltration, Ultracentrifugation), By Product & Services (Instrument), By End Use (CROs), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

Protein Binding Assays Market Growth & Trends:

The global protein binding assays market size is expected to reach USD 896.3 million by 2030 at a CAGR of 10.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.

Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.

These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.

Protein Binding Assays Market Report Highlights:

  • The services segment dominated with a market share of 44.7% in 2023. Technological advancements, strategic investments, and increasing consumer demand constitute market growth.
  • The equilibrium dialysis dominated with a share of 49.7% in 2023. Scientists and researchers prefer this technique due to its low price and high accuracy.
  • The pharmaceuticals and biotechnology segment dominated with a 46.4% market share in 2023. Factors such as a wide and strong distribution network and significant investments in drug discovery boost the segment growth.
  • The North America protein binding assays dominated the global market with a share of 40.8% in 2023.
Show more
Product Code: GVR-3-68038-593-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Protein Binding Assay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Protein Binding Assay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats From New Entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Protein Binding Assay Market: Product & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Protein Binding Assay Market: Product & Services Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instrument
    • 4.3.1. Instrument Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Protein Binding Assay Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Protein Binding Assay Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ultracentrifugation
    • 5.3.1. Ultracentrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Equilibrium Dialysis
    • 5.4.1. Equilibrium Dialysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ultrafiltration
    • 5.5.1. Ultrafiltration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Surface Plasmon Resonance
    • 5.6.1. Surface Plasmon Resonance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Protein Binding Assay Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Protein Binding Assay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Contract Research Organizations
    • 6.3.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Protein Binding Assay Market: Regional Estimates & Trend Analysis

  • 7.1. Protein Binding Assay Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Italy Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Norway
      • 7.3.7.1. Norway Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Denmark Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. ADMEcell, Inc
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Sartorius Stedim BioOutsource Limited
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Abzena Ltd
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Abcam Plc
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. GVK Biosciences Private Limited
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Arryait Corporation
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Charles River Laboratories
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. Sovicell
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
    • 8.4.13. Eurofins Scientific
      • 8.4.13.1. Participant's Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Recent Developments/ Strategic Initiatives
    • 8.4.14. 3B Pharmaceuticals
      • 8.4.14.1. Participant's Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Recent Developments/ Strategic Initiatives
    • 8.4.15. Creative Biolabs
      • 8.4.15.1. Participant's Overview
      • 8.4.15.2. Financial Performance
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Recent Developments/ Strategic Initiatives
    • 8.4.16. Evotec SE
      • 8.4.16.1. Participant's Overview
      • 8.4.16.2. Financial Performance
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Recent Developments/ Strategic Initiatives
    • 8.4.17. BioDuro-Sundia
      • 8.4.17.1. Participant's Overview
      • 8.4.17.2. Financial Performance
      • 8.4.17.3. Product Benchmarking
      • 8.4.17.4. Recent Developments/ Strategic Initiatives
    • 8.4.18. Merck KGaA
      • 8.4.18.1. Participant's Overview
      • 8.4.18.2. Financial Performance
      • 8.4.18.3. Product Benchmarking
      • 8.4.18.4. Recent Developments/ Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!